250 related articles for article (PubMed ID: 21660486)
41. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.
Norman GL; Yang CY; Ostendorff HP; Shums Z; Lim MJ; Wang J; Awad A; Hirschfield GM; Milkiewicz P; Bloch DB; Rothschild KJ; Bowlus CL; Adamopoulos IE; Leung PS; Janssen HJ; Cheung AC; Coltescu C; Gershwin ME
Liver Int; 2015 Feb; 35(2):642-51. PubMed ID: 25243383
[TBL] [Abstract][Full Text] [Related]
42. [Frequencies of autoantibodies specific for primary biliary cirrhosis in a general adult population group].
Liu HY; Wang LX; Liu YF
Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):922-5. PubMed ID: 19105938
[TBL] [Abstract][Full Text] [Related]
43. Clinical significance and prevalence of anti-Saccharomyces cerevisiae antibody in Chinese patients with primary biliary cirrhosis.
Hu C; Deng C; Zhang S; Song G; Li L; Li X; Wang L; Zhang F; Li Y
Clin Exp Med; 2013 Nov; 13(4):245-50. PubMed ID: 22983759
[TBL] [Abstract][Full Text] [Related]
44. The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis.
Yang F; Wang Q; Wang Z; Miao Q; Xiao X; Tang R; Chen X; Bian Z; Zhang H; Yang Y; Sheng L; Fang J; Qiu D; Krawitt EL; Gershwin ME; Ma X
Clin Rev Allergy Immunol; 2016 Feb; 50(1):114-23. PubMed ID: 26411425
[TBL] [Abstract][Full Text] [Related]
45. Correlation of autoantibodies presence detected by IFA-anti-dsDNA, IFA-AMA and immunoblotting with corresponding data in clinical management of autoimmune diseases.
Subasić D; Karamehić J; Ljuca F; Gavrankapetanović F; Delić-Sarac M; Eminović I; Kovacević D
Bosn J Basic Med Sci; 2008 Feb; 8(1):86-92. PubMed ID: 18318679
[TBL] [Abstract][Full Text] [Related]
46. [Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].
Liu HH; Fu JL; Xu J; Luo SQ; Liu ZW; Wang FS
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):233-7. PubMed ID: 23591343
[TBL] [Abstract][Full Text] [Related]
47. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
[TBL] [Abstract][Full Text] [Related]
48. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?
Muratori P; Muratori L; Gershwin ME; Czaja AJ; Pappas G; MacCariello S; Granito A; Cassani F; Loria P; Lenzi M; Bianchi FB
Clin Exp Immunol; 2004 Jan; 135(1):154-8. PubMed ID: 14678277
[TBL] [Abstract][Full Text] [Related]
49. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656
[TBL] [Abstract][Full Text] [Related]
50. Relationship between autoimmune liver disease and autoimmune thyroid disease: a cross-sectional study.
Zeng Q; Zhao L; Wang C; Gao M; Han X; Chen C; Tu C; Han P; Li J
Scand J Gastroenterol; 2020 Feb; 55(2):216-221. PubMed ID: 32083943
[No Abstract] [Full Text] [Related]
51. Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group.
Gatselis NK; Zachou K; Loza AJM; Cançado ELR; Arinaga-Hino T; Muratori P; Efe C; Floreani A; Invernizzi P; Takahashi A; Takaki A; Beretta-Piccoli BT; van Hoek B; Lytvyak E; Guedes LV; Purnak T; Cazzagon N; Lygoura V; Arvaniti P; Rigopoulou EI; Muratori L; Dalekos GN;
Eur J Intern Med; 2023 Oct; 116():43-50. PubMed ID: 37302951
[TBL] [Abstract][Full Text] [Related]
52. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.
Bogdanos DP; Baum H; Butler P; Rigopoulou EI; Davies ET; Ma Y; Burroughs AK; Vergani D
Dig Liver Dis; 2003 Nov; 35(11):801-5. PubMed ID: 14674671
[TBL] [Abstract][Full Text] [Related]
53. A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis.
Lian JS; Liu W; Hao SR; Chen DY; Wang YY; Yang JL; Jia HY; Huang JR
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):413-21. PubMed ID: 26256087
[TBL] [Abstract][Full Text] [Related]
54. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
55. Autoantibody Profile of Adult Patients With Childhood Onset Type 2 Autoimmune Hepatitis.
Woynarowski M; Woźniak M; Cukrowska B; Wierzbicka A; Lytton SD
J Clin Lab Anal; 2016 Sep; 30(5):590-6. PubMed ID: 26676069
[TBL] [Abstract][Full Text] [Related]
56. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
57. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
[TBL] [Abstract][Full Text] [Related]
58. The contribution of antinuclear antibodies in Primary Biliary Cholangitis (PBC): An experience from the immunology laboratory at University Hospital Center Hassan II, Fes, Morocco.
Mitri IE; Kaaouch H; Ouboks M; Ballil O
Qatar Med J; 2023; 2023(2):27. PubMed ID: 38025334
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of autoantibodies directed against nuclear and cytoplasmic antigens in autoimmune liver disease.
McLean F
Br J Biomed Sci; 2013; 70(1):10-4. PubMed ID: 23617092
[TBL] [Abstract][Full Text] [Related]
60. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
Itoh S; Ichida T; Yoshida T; Hayakawa A; Uchida M; Tashiro-Itoh T; Matsuda Y; Ishihara K; Asakura H
J Gastroenterol Hepatol; 1998 Mar; 13(3):257-65. PubMed ID: 9570238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
